Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 6:35 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1057–1080 of 6,918 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Stimulation Clear all

Conditions: Infant Feeding Problems, taVNS
Interventions: transcutaneous auricular vagus nerve stimulation, Sham transcutaneous auricular vagus nerve stimulation; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 2 Weeks to 5 Months
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Parkinson's Disease (PD)
Interventions: TMS+ Gait training; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 50 Years to 80 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Post-Concussion Syndrome, Concussion, Brain, Mild Traumatic Brain Injury, Head Injury, Headache, Dizziness, Cognitive Symptom, Dysautonomia, Anxiety, Irritability; Syndrome, Depression, Post-traumatic Stress Disorder
Interventions: Active cTBS, Inactive/Sham cTBS, Imaginal exposure; Device · Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 65 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Westwood, Los Angeles, California

Conditions: Spinal Cord Injuries
Interventions: Robotic Gait Training, Usual Care (UC) Gait Training; Device · Other
Lead sponsor: Baylor Research Institute; Other
Eligibility: 16 Years to 85 Years
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome
Interventions: Azacitidine, Sargramostim; Drug · Biological
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 6 Months and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2020
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Effect of tDCS on Memory in Older and Younger Adults
Interventions: Active tDCS, Sham tDCS; Device
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 75 Years
Enrollment: 271 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Infertility, Female, Ovarian Follicular Cyst
Interventions: Follicle Clarity; Device
Lead sponsor: Cycle Clarity; Industry
Eligibility: 21 Years to 42 Years · Female only
Enrollment: 80 participants
Timeline: 2021
U.S. locations: 1
States / cities: Mt. Pleasant, South Carolina

Conditions: Insomnia
Interventions: CBTI-CS, Sleep Hygiene, CBTI-CS via Telehealth; Behavioral
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Traumatic Brain Injury
Interventions: tDCS, [11C] Raclopride; Device · Drug
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years to 60 Years
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2024
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Cocaine Dependence, Alcohol Dependence
Interventions: Real cTBS, Sham cTBS; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 21 Years to 65 Years
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 2
States / cities: Charleston, South Carolina

Conditions: Stroke
Interventions: Operant conditioning of motor evoked potentials; Other
Lead sponsor: University of Houston; Other
Eligibility: 40 Years to 75 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Abdominal Pain, Irritable Bowel Syndrome
Interventions: synthetic human secretin; Drug
Lead sponsor: Orlando Health, Inc.; Other
Eligibility: 6 Months to 18 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Depression
Interventions: Psilocybin, Transcutaneous Auricular Vagus Nerve Stimulation (taVNS), Sham taVNS; Drug · Device
Lead sponsor: Charles Raison; Other
Eligibility: 18 Years to 70 Years
Enrollment: 141 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Edwards, Colorado

Conditions: Chronic Pain
Interventions: WaveWriter, Conventional Medical Managament; Device · Other
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 22 Years and older
Enrollment: 241 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 23
States / cities: Palm Desert, California • Santa Rosa, California • Greenwood Village, Colorado + 19 more

Conditions: Spinal Cord Injury
Interventions: Blood flow-restricted exercise; Behavioral
Lead sponsor: Quality Living, Inc.; Other
Eligibility: 19 Years to 75 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Parkinson Disease
Interventions: Stimulation; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 22 Years to 85 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Anemia, Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
Interventions: epoetin alfa, thalidomide; Biological · Drug
Lead sponsor: Fallon Clinic; Industry
Eligibility: 21 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2007
U.S. locations: 2
States / cities: Worcester, Massachusetts

Conditions: Overweight, Obesity
Interventions: Transcutaneous Nerve Stimulator (TENS), Diet & Exercise; Device · Behavioral
Lead sponsor: Elira Therapeutics, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Ewing's Sarcoma, Neuroblastoma, Rhabdomyosarcoma
Interventions: ADR-529, Topotecan, G-CSF; Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: Not listed
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1993 – 2002
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Schizophrenia
Interventions: transcranial direct current stimulation; Procedure
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 79 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Colorectal Cancer, Esophageal Cancer, Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Gastric Cancer, Pancreatic Cancer, Small Intestine Cancer
Interventions: carcinoembryonic antigen peptide 1-6D, incomplete Freund's adjuvant, sargramostim; Biological
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 18 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2006
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Triple-negative Breast Cancer
Interventions: Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody, Placebo, Nab-paclitaxel, Doxorubicin, Cyclophosphamide, Filgrastim, Pegfilgrastim; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years and older
Enrollment: 333 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 12
States / cities: Palo Alto, California • Norwalk, Connecticut • Carrollton, Georgia + 8 more

Conditions: Hypertension
Interventions: Abatacept, Placebo; Drug
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Parkinson's Disease
Interventions: Medtronic DBS system; Device
Lead sponsor: MedtronicNeuro; Industry
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 2
States / cities: La Jolla, California • Kansas City, Kansas

Search by objective public record fields.

BabyStrong Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) Paired Bottle Feeding to Improve Oral Feeding

Accelerated TMS for Freezing of Gait in Parkinson's Disease

Personalized Brain Stimulation to Treat Chronic Concussive Symptoms

Dosing of Overground Robotic Gait Training With Functional Outcomes and Neuroplasticity After Spinal Cord Injury

Phase II Study of Azacitidine and Sargramostim as Maintenance Treatment for Poor-Risk AML or MDS

Effect of Noninvasive Electrical Brain Stimulation on Memory at Different Times of Day in Younger and Older Adults

Convolutional Neural Network in Ovarian Follicle Identification

CBTI-CS: A Novel Cognitive-Behavioral Treatment for Insomnia in Cancer Survivors

Neural Basis of Decision-Making Deficits in Traumatic Brain Injury

10 Days of Theta Burst Stimulation as a Tool to Treat Cocaine Dependence

Operant Conditioning for Rehabilitation After Stroke

Recurrent Abdominal Pain and Exocrine Pancreatic Insufficiency

Investigation to Understand and Optimize Psilocybin

SCS as an Option for Chronic Low Back and/or Leg Pain Instead of Surgery

Effect of Blood Flow-restricted Exercise Frequency on Strength Recovery Following Incomplete SCI

Circuit-Based Deep Brain Stimulation for Parkinson's Disease; Udall Project 1 Aim 2 and 3

Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome

Safety and Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS)-Assisted Weight Loss

New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and Neuroblastoma

Effects of Transcranial Direct Current Stimulation in Individuals With Schizophrenia

Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract

A Study to Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast Cancer

Treatment of Resistant Hypertension by Prevention of T-Cell Co-Stimulation

Retrospective, Non-significant Risk, Deep Brain Stimulation (DBS) Care Management Software Feasibility Study